Terms: = Lymphoma AND MDM2, HDM2, 4193, ENSG00000135679, HDMX, MGC71221, hdm2, Q00987 AND Clinical Outcome
13 results:
1. Aggressive B-cell lymphoma with MYC/TP53 Dual Alterations Displays Distinct Clinicopathobiological Features and Response to Novel Targeted Agents.
Deng M; Xu-Monette ZY; Pham LV; Wang X; Tzankov A; Fang X; Zhu F; Visco C; Bhagat G; Dybkaer K; Chiu A; Tam W; Zu Y; Hsi ED; You H; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Parsons BM; Hagemeister F; van Krieken JH; Piris MA; Winter JN; Li Y; Xu B; Liu P; Young KH
Mol Cancer Res; 2021 Feb; 19(2):249-260. PubMed ID: 33154093
[TBL] [Abstract] [Full Text] [Related]
2. mdm2 phenotypic and genotypic profiling, respective to TP53 genetic status, in diffuse large B-cell lymphoma patients treated with rituximab-CHOP immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
Xu-Monette ZY; Møller MB; Tzankov A; Montes-Moreno S; Hu W; Manyam GC; Kristensen L; Fan L; Visco C; Dybkaer K; Chiu A; Tam W; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huang Q; Huh J; Ai W; Ponzoni M; Ferreri AJ; Wu L; Zhao X; Bueso-Ramos CE; Wang SA; Go RS; Li Y; Winter JN; Piris MA; Medeiros LJ; Young KH
Blood; 2013 Oct; 122(15):2630-40. PubMed ID: 23982177
[TBL] [Abstract] [Full Text] [Related]
3. Follicular lymphoma in young adults: a clinicopathological and molecular study of 200 patients.
Duarte IX; Domeny-Duarte P; Wludarski SC; Natkunam Y; Bacchi CE
Mod Pathol; 2013 Sep; 26(9):1183-96. PubMed ID: 23599146
[TBL] [Abstract] [Full Text] [Related]
4. Correlation of seven biological factors (Hsp90a, p53, mdm2, Bcl-2, Bax, Cytochrome C, and Cleaved caspase3) with clinical outcomes of ALK+ anaplastic large-cell lymphoma.
Li HL; Huang XP; Zhou XH; Ji TH; Wu ZQ; Wang ZQ; Jiang HY; Liu FR; Zhao T
Biomed Environ Sci; 2011 Dec; 24(6):630-41. PubMed ID: 22365399
[TBL] [Abstract] [Full Text] [Related]
5. Novel targeted therapeutics: inhibitors of mdm2, ALK and PARP.
Yuan Y; Liao YM; Hsueh CT; Mirshahidi HR
J Hematol Oncol; 2011 Apr; 4():16. PubMed ID: 21504625
[TBL] [Abstract] [Full Text] [Related]
6. Improved demonstration of immunohistochemical prognostic markers for survival in follicular lymphoma cells.
Camacho FI; Bellas C; Corbacho C; Caleo A; Arranz-Sáez R; Cannata J; Menárguez J; Sánchez-Verde L; González-Camacho L; Pérez-Martín ME; Martínez-González MA; Alvaro T; Mollejo M; Ruíz-Marcellán C; Montalbán C; Piris MA
Mod Pathol; 2011 May; 24(5):698-707. PubMed ID: 21240256
[TBL] [Abstract] [Full Text] [Related]
7. p53 and mdm2 in mantle cell lymphoma in leukemic phase.
Solenthaler M; Matutes E; Brito-Babapulle V; Morilla R; Catovsky D
Haematologica; 2002 Nov; 87(11):1141-50. PubMed ID: 12414343
[TBL] [Abstract] [Full Text] [Related]
8. Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays.
García JF; Camacho FI; Morente M; Fraga M; Montalbán C; Alvaro T; Bellas C; Castaño A; Díez A; Flores T; Martin C; Martinez MA; Mazorra F; Menárguez J; Mestre MJ; Mollejo M; Sáez AI; Sánchez L; Piris MA;
Blood; 2003 Jan; 101(2):681-9. PubMed ID: 12393683
[TBL] [Abstract] [Full Text] [Related]
9. p53 over-expression identifies a subset of nodal peripheral T-cell lymphomas with a distinctive biological profile and poor clinical outcome.
Pescarmona E; Pignoloni P; Puopolo M; Martelli M; Addesso M; Guglielmi C; Baroni CD
J Pathol; 2001 Oct; 195(3):361-6. PubMed ID: 11673835
[TBL] [Abstract] [Full Text] [Related]
10. Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease.
Smolewski P; Niewiadomska H; Los E; Robak T
Int J Oncol; 2000 Sep; 17(3):603-9. PubMed ID: 10938405
[TBL] [Abstract] [Full Text] [Related]
11. The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Faderl S; Kantarjian HM; Manshouri T; Chan CY; Pierce S; Hays KJ; Cortes J; Thomas D; Estrov Z; Albitar M
Clin Cancer Res; 1999 Jul; 5(7):1855-61. PubMed ID: 10430092
[TBL] [Abstract] [Full Text] [Related]
12. Chromosomal and gene amplification in diffuse large B-cell lymphoma.
Rao PH; Houldsworth J; Dyomina K; Parsa NZ; Cigudosa JC; Louie DC; Popplewell L; Offit K; Jhanwar SC; Chaganti RS
Blood; 1998 Jul; 92(1):234-40. PubMed ID: 9639522
[TBL] [Abstract] [Full Text] [Related]
13. clinical outcome in diffuse large B-cell lymphoma is dependent on the relationship between different cell-cycle regulator proteins.
Sanchez E; Chacon I; Plaza MM; Muñoz E; Cruz MA; Martinez B; Lopez L; Martinez-Montero JC; Orradre JL; Saez AI; Garcia JF; Piris MA
J Clin Oncol; 1998 May; 16(5):1931-9. PubMed ID: 9586912
[TBL] [Abstract] [Full Text] [Related]
